FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

363688001: Administration of antineoplastic agent (procedure)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
484998010 Administration of antineoplastic agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
762910019 Administration of antineoplastic agent (procedure) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1815421000195113 somministrazione di agente anti-neoplastico it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3396670015 administration d'un antinéoplasique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3396673018 administration d'un agent antinéoplasique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

37 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Administration of antineoplastic agent Is a Administration of medication false Inferred relationship Some
Administration of antineoplastic agent Direct substance agent antinéoplasique false Inferred relationship Some
Administration of antineoplastic agent Method Administration - action false Inferred relationship Some 1
Administration of antineoplastic agent Direct substance Antineoplastic agent (substance) false Inferred relationship Some 1
Administration of antineoplastic agent Direct substance A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. false Inferred relationship Some 1
Administration of antineoplastic agent Method Introduction of substance false Inferred relationship Some 1
Administration of antineoplastic agent Method Administration - action false Inferred relationship Some 1
Administration of antineoplastic agent Direct substance Antineoplastic agent (substance) false Inferred relationship Some 1
Administration of antineoplastic agent Method Administration - action true Inferred relationship Some 1
Administration of antineoplastic agent Direct substance Antineoplastic agent (substance) true Inferred relationship Some 1
Administration of antineoplastic agent Is a The treatment of disease using chemical agents or drugs that are selectively toxic to the causative agent of the disease, such as a virus, bacterium, or other microorganism. true Inferred relationship Some
Administration of antineoplastic agent Has intent Therapeutic false Inferred relationship Some 2
Inbound Relationships Type Active Source Characteristic Refinability Group
Chemotherapy administration, subcutaneous, with local anesthesia Is a True Administration of antineoplastic agent Inferred relationship Some
Chemotherapy administration into peritoneal cavity requiring paracentesis Is a False Administration of antineoplastic agent Inferred relationship Some
Chemotherapy administration into pleural cavity requiring thoracentesis Is a True Administration of antineoplastic agent Inferred relationship Some
Cytotoxic given orally Is a False Administration of antineoplastic agent Inferred relationship Some
Intra-arterial infusion of antineoplastic agent Is a True Administration of antineoplastic agent Inferred relationship Some
Intravenous chemotherapy administration by push technique Is a False Administration of antineoplastic agent Inferred relationship Some
Intrathecal injection of chemotherapeutic agent Is a True Administration of antineoplastic agent Inferred relationship Some
Infusion chemotherapy for malignant neoplasm Is a True Administration of antineoplastic agent Inferred relationship Some
Intravenous injection of methotrexate (procedure) Is a False Administration of antineoplastic agent Inferred relationship Some
Intramuscular injection of methotrexate (procedure) Is a False Administration of antineoplastic agent Inferred relationship Some
BCG vaccination Is a False Administration of antineoplastic agent Inferred relationship Some
chimiothérapie subcutanée Is a False Administration of antineoplastic agent Inferred relationship Some
Injection of cytotoxic substance into artery of head (procedure) Is a False Administration of antineoplastic agent Inferred relationship Some
chimiothérapie intraveineuse Is a False Administration of antineoplastic agent Inferred relationship Some
Injection of chemotherapeutic substance into subcutaneous reservoir Is a False Administration of antineoplastic agent Inferred relationship Some
Methotrexate injection into tubal pregnancy Is a False Administration of antineoplastic agent Inferred relationship Some
Photochemotherapy with psoralens and ultraviolet A Is a False Administration of antineoplastic agent Inferred relationship Some
Injection of chemotherapeutic substance into tumor of brain tissue Is a False Administration of antineoplastic agent Inferred relationship Some
Intraperitoneal administration of cytotoxic drug Is a False Administration of antineoplastic agent Inferred relationship Some
Subcutaneous injection of methotrexate (procedure) Is a False Administration of antineoplastic agent Inferred relationship Some
Administration of prophylactic antineoplastic agent Is a False Administration of antineoplastic agent Inferred relationship Some
Trabeculectomy with intraoperative administration of antimetabolite Is a False Administration of antineoplastic agent Inferred relationship Some
Injection of interferon (procedure) Is a False Administration of antineoplastic agent Inferred relationship Some
Postoperative administration of antineoplastic agent into peritoneal cavity Is a False Administration of antineoplastic agent Inferred relationship Some
Raloxifene therapy (procedure) Is a False Administration of antineoplastic agent Inferred relationship Some
Administration of cytotoxic agent via oral route (procedure) Is a False Administration of antineoplastic agent Inferred relationship Some
Administration of chemotherapeutic agent into urinary bladder via intravesical route Is a False Administration of antineoplastic agent Inferred relationship Some
Cyclophosphamide therapy (procedure) Is a False Administration of antineoplastic agent Inferred relationship Some
Parenteral chemotherapy for malignant neoplasm Is a True Administration of antineoplastic agent Inferred relationship Some
Perfusion chemotherapy for malignant neoplasm Is a True Administration of antineoplastic agent Inferred relationship Some
Topical chemotherapy for malignant neoplasm Is a True Administration of antineoplastic agent Inferred relationship Some
Intracavitary chemotherapy for malignant neoplasm Is a True Administration of antineoplastic agent Inferred relationship Some
Local chemotherapy for malignant neoplasm Is a True Administration of antineoplastic agent Inferred relationship Some
Administration of antineoplastic chemotherapy that imitates the effect of radiation. Is a True Administration of antineoplastic agent Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Due to True Administration of antineoplastic agent Inferred relationship Some 1
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent After True Administration of antineoplastic agent Inferred relationship Some 2
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbour unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). After True Administration of antineoplastic agent Inferred relationship Some 2
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbour unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). Due to True Administration of antineoplastic agent Inferred relationship Some 3
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving the mixed lineage leukaemia gene at 11q23. This subgroup of t-MN is typically associated with overt leukaemia, without preceding myelodysplastic syndrome, developing 2-3 years after exposure, presenting with non-specific symptoms related to ineffective haematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement. After True Administration of antineoplastic agent Inferred relationship Some 2
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving the mixed lineage leukaemia gene at 11q23. This subgroup of t-MN is typically associated with overt leukaemia, without preceding myelodysplastic syndrome, developing 2-3 years after exposure, presenting with non-specific symptoms related to ineffective haematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement. Due to True Administration of antineoplastic agent Inferred relationship Some 3
Administration of consolidation antineoplastic agent (procedure) Is a True Administration of antineoplastic agent Inferred relationship Some
Administration of hyperthermic antineoplastic agent into peritoneal cavity Is a False Administration of antineoplastic agent Inferred relationship Some
Administration of hyperthermic antineoplastic agent into thoracic cavity (procedure) Is a True Administration of antineoplastic agent Inferred relationship Some
Peripheral neuropathy due to and following antineoplastic therapy (disorder) After True Administration of antineoplastic agent Inferred relationship Some 1
Peripheral neuropathy due to and following antineoplastic therapy (disorder) Due to True Administration of antineoplastic agent Inferred relationship Some 3
Multi-agent systemic chemotherapy Is a True Administration of antineoplastic agent Inferred relationship Some
Administration of antineoplastic chemotherapeutic agent(s) which may be individual instances or separate times over a pre-determined or planned period of days or weeks. Is a True Administration of antineoplastic agent Inferred relationship Some
Agranulocytosis due to and following administration of antineoplastic agent (disorder) Due to True Administration of antineoplastic agent Inferred relationship Some 3
Agranulocytosis due to and following administration of antineoplastic agent (disorder) After True Administration of antineoplastic agent Inferred relationship Some 1
Ulcerative inflammation of oral mucous membrane due to and following administration of antineoplastic agent (disorder) Due to True Administration of antineoplastic agent Inferred relationship Some 3
Ulcerative inflammation of oral mucous membrane due to and following administration of antineoplastic agent (disorder) After True Administration of antineoplastic agent Inferred relationship Some 2
Palliative antineoplastic chemotherapy Is a True Administration of antineoplastic agent Inferred relationship Some
Administration of antineoplastic chemotherapy into peritoneal cavity (procedure) Is a True Administration of antineoplastic agent Inferred relationship Some
A type of cancer treatment that targets specific genes and proteins to prevent cancer cells surviving, growing or duplicating e.g. small molecule drugs or monoclonal antibodies. Is a True Administration of antineoplastic agent Inferred relationship Some
Neoadjuvant antineoplastic chemotherapy (procedure) Is a True Administration of antineoplastic agent Inferred relationship Some
A rare neoplastic disorder characterized by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumors of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumor markers have normalized. The retroperitoneum is the most common site, although almost any other localization has been reported. Increased tumor size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischemia, and biliary obstruction as major complications. After True Administration of antineoplastic agent Inferred relationship Some 2
Administration of antineoplastic agent via intravenous route (procedure) Is a True Administration of antineoplastic agent Inferred relationship Some
Administration of antineoplastic agent via subcutaneous route (procedure) Is a True Administration of antineoplastic agent Inferred relationship Some
Heart failure following administration of antineoplastic agent After True Administration of antineoplastic agent Inferred relationship Some 2
Anastrozole therapy Is a True Administration of antineoplastic agent Inferred relationship Some
Methotrexate therapy (procedure) Is a True Administration of antineoplastic agent Inferred relationship Some

This concept is not in any reference sets

Back to Start